Bispecific Antibodies Look Promising in Follicular Lymphoma
The use of bispecific antibodies has the potential to revolutionize the management of FL.
How Will New Immunotherapies Fit Into the Treatment Landscape of Follicular Lymphoma?
Future directions for follicular lymphoma treatments include potential use earlier in treatment or as combination therapy, identifying patients who will benefit most from treatment, and minimizing the costs of therapy while maximizing accessibility.
Unmet Needs and Emerging Treatments in DLBCL
Closing out the program, Dr Gilles Salles highlights currently unmet needs in DLBCL and investigational treatments he finds exciting.
Factors for Treatment Decision-Making in R/R DLBCL
Dr Gilles Salles shares his opinion on the presented case’s treatment decision and the regimen he would have selected for the patient.
Safety Data on the Pola-BR Regimen in R/R DLBCL
Gilles Salles, MD, PhD, explains data on the adverse events seen with the pola-BR regimen in R/R DLBCL during the GO29365 clinical trial.
Efficacy Data on the Pola-BR Regimen in R/R DLBCL
A review of population, dosing, and efficacy data from the GO29365 clinical trial investigating the combination of polatuzumab, bendamustine, and rituximab (pola-BR) for R/R DLBCL.
Available Third-Line Treatment Regimens in R/R DLBCL
Dr Salles provides an overview of the available third-line treatment options for patients with R/R DLBCL who are ineligible for or do not wish to receive autologous stem cell transplant or CAR T-cell therapy.
The Challenges of Disease Management in R/R DLBCL
An oncologist describes the typical major challenges of managing patients with R/R DLBCL and the incidence of relapsed or refractory disease.
Introduction: A 51-Year-Old Woman with DLBCL
Gilles Salles, MD, PhD, presents the case of a 51-year-old woman with relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL).
Novel Treatment Options in Diffuse Large B-Cell Lymphoma
L-MIND Trial Regimen Overview
Results of the L-MIND Clinical Trial
Initial Treatment of Diffuse Large B-Cell Lymphoma
Presentation of a Patient With Diffuse Large B-Cell Lymphoma
A 74-Year-Old Man With Diffuse Large B-Cell Lymphoma
Gilles Salles, MD, reviews the case of a 74-year-old man with diffuse large B-cell lymphoma.
2 Clarke Drive Cranbury, NJ 08512